Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve Castration-Resistant Prostate Cancer

Publication Date: April 25, 2017

Last Updated: April 2, 2024

Key Points

Men who develop castration-resistant prostate cancer (CRPC) despite castrate levels of testosterone should be maintained in a castrate state indefinitely.

Treatment

Algorithm for Second-line Hormonal CRPC Treatment

Overview

Title